CATALENT - BLOW-FILL-SEAL STERILE CONTRACT DEVELOPMENT AND MANUFACTURING BUSINESS
Blow-Fill-Seal Sterile CDMO Business is focusing on complex clinical to commercial-stage formulation and manufacturing. The Business supports a global, blue-chip customer base with a broad array of products that leverage its BFS sterile manufacturing capabilities and formulation competency in complex chemistries including small molecule, biologics, macromolecules, and potent compounds.
CATALENT - BLOW-FILL-SEAL STERILE CONTRACT DEVELOPMENT AND MANUFACTURING BUSINESS
Industry:
Biotechnology Health Care Manufacturing Pharmaceutical
Address:
Somerset, New Jersey, United States
Country:
United States
Status:
Active
Similar Organizations
GJ Chemical Co. Inc
GJ Chemical Co. Inc is a chemical company that provides pharmaceutical and industrial acids.
Pharmaceutical Processing
Pharmaceutical Processing is the leading source of pharmaceutical and biopharmaceutical manufacturing news.
More informations about "Catalent - Blow-Fill-Seal Sterile Contract Development and Manufacturing Business"
SK Capital Closes Acquisition of Catalent’s Blow-Fill-Seal Sterile …
New York, March 31, 2021 – Funds managed by SK Capital Partners LP, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, completed the …See details»
Catalent Divests Blow-Fill-Seal Sterile CDMO Business
Jan 7, 2021 SK Capital Partners, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, has acquired the Blow-Fill-Seal (BFS) sterile contract …See details»
SK Capital Announces Agreement to Acquire Catalent’s Blow-Fill …
New York, January 6, 2021 – SK Capital Partners LP, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, today announced that funds it …See details»
SK Capital Completes Acquisition of Catalent’s Blow-Fill-Seal CDMO
Apr 1, 2021 SK Capital Partners, a private investment firm focused on the specialty materials, chemicals, and pharmaceuticals sectors, announced on March 31, 2021 it has completed its …See details»
SK Capital Announces Agreement to Acquire Catalent’s Blow-Fill …
Jan 6, 2021 The Business is a leading BFS sterile contract development and manufacturing organization (CDMO) that operates out of a single site in Woodstock, Illinois, focusing on …See details»
SK Capital Partners to acquire blow-fill-seal unit of Catalent …
Jan 7, 2021 Funds advised by private equity firm SK Capital Partners agreed to acquire the blow-fill-seal sterile contract development and manufacturing business of Catalent Pharma …See details»
SK Capital Closes Acquisition of Catalent’s Blow- Fill-Seal Sterile ...
The previously announced acquisition of the Blow-Fill-Seal (“BFS”) Sterile Contract Development and Manufacturing business from Catalent Pharma Solutions, LLC. The business has been …See details»
SK Capital Announces Agreement to Acquire Catalent’s Blow-Fill …
Advises have signed a definitive agreement to acquire the Blow-Fill-Seal (“BFS”) Sterile Contract Development and Manufacturing Business (the “Business”) from Catalent Pharma Solutions, …See details»
SK Capital Closes Acquisition of Catalent’s Blow-Fill …
New York, March 31, 2021 – Funds managed by SK Capital Partners LP, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, completed the previously announced acquisition of …See details»
Deal for Catalent’s blow-fill-seal business now official
Apr 1, 2021 SK Capital Partners LP, a private investment firm that focuses on the specialty materials, chemicals and pharmaceuticals sectors, has formally completed the previously …See details»
SK Capital Announces Agreement to Acquire Catalent’s Blow-Fill …
Jan 6, 2021 NEW YORK--(BUSINESS WIRE)-- SK Capital Partners LP, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, today …See details»
Catalent inks deal to offload blow-fill-seal business to SK Capital
Jan 6, 2021 Private equity firm SK Capital is ponying up an undisclosed sum to purchase Catalent’s blow-fill-seal sterile CDMO business. With a definitive agreement locked down, the …See details»
SK Capital Closes Acquisition of Catalent’s Blow-Fill-Seal Sterile …
Mar 31, 2021 NEW YORK--(BUSINESS WIRE)-- Funds managed by SK Capital Partners LP, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals …See details»
Catalent - Crunchbase Company Profile & Funding
Blow-Fill-Seal Sterile CDMO Business is focusing on complex clinical to commercial-stage formulation and manufacturing. The Business supports a global, blue-chip customer base with …See details»
SK Capital Announces Agreement to Acquire Catalent’s Blow-Fill …
Jan 6, 2021 SK Capital Partners LP, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, today announced that funds it advises have …See details»
SK Capital Closes Acquisition of Catalent’s Blow-Fill-Seal Sterile …
Aug 12, 2023 NEW YORK--(BUSINESS WIRE)-- Funds managed by SK Capital Partners LP, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals …See details»
Catalent Pharma's BFS business to be sold to SK Capital in LBO
Jan 6, 2021 Cerberus Business Finance LLC committed to providing debt financing backing an acquisition of Blow-Fill-Seal (BFS) Sterile Contract Development and Manufacturing Business, …See details»
Catalent - Blow-Fill-Seal Sterile Contract Development and ...
Jul 6, 2021 Catalent (NYSE:CTLT) provides advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. Use the CB Insights Platform to …See details»
SK Capital Announces Agreement to Acquire Catalent’s Blow-Fill …
Jan 15, 2021 SK Capital Partners LP, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, today announced that funds it advises have …See details»
SK Capital Closes Acquisition of Catalent’s Blow-Fill-Seal Sterile …
Mar 31, 2021 Funds managed by SK Capital Partners LP, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, completed the previously …See details»